These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 621814)

  • 21. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
    Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
    Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
    Abe R
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
    Das G
    Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
    [No Abstract]   [Full Text] [Related]  

  • 25. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression.
    Yamada T; Fukui I; Yokokawa M; Oshima H
    Cancer; 1988 Feb; 61(4):721-6. PubMed ID: 3338034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood group ABH-related antigens in normal and malignant bladder urothelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas.
    Orntoft TF; Wolf H; Clausen H; Dabelsteen E; Hakomori S
    Int J Cancer; 1989 May; 43(5):774-80. PubMed ID: 2497072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between HLA antigens and bladder tumors.
    Tokuç R; Akdaş A; Ozerkan K; Remzi D
    Eur Urol; 1987; 13(3):207-9. PubMed ID: 3497040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The specific erythrocyte adherence method in the study of ABH antigens on normal and neoplastic bladder epithelium].
    Ongaro G; Issi M; Gallo T; Garbeglio A; Ranieri A; Dalla Palma P
    Quad Sclavo Diagn; 1983 Jun; 19(2):242-61. PubMed ID: 6676774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder.
    Yamada T; Fukui I; Kobayashi T; Sekine H; Yokogawa M; Yamada T; Oshima H
    Cancer; 1991 Mar; 67(6):1661-6. PubMed ID: 2001555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
    Kumon H; Nasu Y; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
    [No Abstract]   [Full Text] [Related]  

  • 32. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma.
    Sadoughi N; Mlsna J; Guinan P; Rubenstone A
    Urology; 1982 Aug; 20(2):143-6. PubMed ID: 7051508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
    Borella T; Loro M; Dato I; Merlo F; Giudici M
    Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.
    Finan PJ; Anderson JR; Doyle PT; Lennox ES; Bleehen NM
    Br J Urol; 1982 Dec; 54(6):720-5. PubMed ID: 6758916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Coon JS; Weinstein RS; Summers JL
    Am J Clin Pathol; 1982 Jun; 77(6):692-9. PubMed ID: 7091049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.